Helga Helseth Hektoen

  • Post doc; PhD

MSc in chemistry with a specialization in cancer epidemiology from the Cancer Registry of Norway, experienced in analyzing national real-world data, with a focus on immunotherapy and survival outcomes in non-small cell lung cancer.

Currently working with the project: Impact of commonly prescribed non-oncology drugs on immunotherapy outcomes.